{
    "Trade/Device Name(s)": [
        "AmpliVue\u2122 C. difficile Assay",
        "AmpliVueT\u2122M C. difficile Assay"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K123355",
    "Predicate Device Reference 510(k) Number(s)": [
        "K113358"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OZN"
    ],
    "Summary Letter Date": "October 26, 2012",
    "Summary Letter Received Date": "November 6, 2012",
    "Submission Date": "December 10, 2012",
    "Regulation Number(s)": [
        "21 CFR 866.3130"
    ],
    "Regulation Name(s)": [
        "C. Difficile Nucleic Acid Amplification Test Assay"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Clostridium difficile Toxin A gene (tcdA)"
    ],
    "Specimen Type(s)": [
        "Unformed stool"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Self-contained disposable amplicon detection device",
        "Manual read cassette"
    ],
    "Method(s)/Technology(ies)": [
        "Helicase-dependent amplification (HDA)",
        "Isothermal nucleic acid amplification",
        "Lateral flow detection"
    ],
    "Methodologies": [
        "Nucleic acid amplification"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Cassette",
        "Cartridge",
        "Tube",
        "Buffer",
        "Swab"
    ],
    "Document Summary": "FDA 510(k) summary for Quidel AmpliVue\u2122 C. difficile Assay for qualitative detection of toxigenic Clostridium difficile from unformed stool via HDA and manual cassette readout.",
    "Indications for Use Summary": "Qualitative detection of the Clostridium difficile Toxin A gene (tcdA) in unformed stool specimens from patients suspected of Clostridium difficile-associated disease, as an aid in diagnosis using helicase-dependent amplification and manual evaluation.",
    "fda_folder": "Microbiology"
}